(HealthDay)—For patients with non-small-cell lung cancer, treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is associated with skin toxic effects, according to a research letter study ...
Dec 11, 2015
0
0
Surgical lung resection, in which part of a lung is removed, can be a safe and effective treatment option for high-risk patients with early stage lung cancer, according to an article posted online by the Annals of Thoracic ...
Nov 10, 2015
0
9
Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location ...
Oct 31, 2015
0
114
(HealthDay)—The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced non-small-cell lung cancer (NSCLC) whose disease progressed despite platinum-based chemotherapy.
Oct 12, 2015
0
16
(HealthDay)—Diacetylspermine is a novel prediagnostic serum biomarker for non-small-cell lung cancer (NSCLC), according to a study published online Aug. 17 in the Journal of Clinical Oncology.
Sep 18, 2015
0
9
Early-stage Non-small-cell Lung Cancer (NSCLC) is asymptomatic and difficult to detect since no blood test for NSCLC is currently available. In a new study, Chen-Yu Zhang and Chunni Zhang's group at Nanjing Advanced Institute ...
Aug 14, 2015
0
11
In the spring of 2012, Tom Stutz was a man without a future. Just getting through the day took all of his energy and determination.
Jun 29, 2015
0
175
(HealthDay)—A new drug that boosts the immune system's cancer-fighting potential is showing early promise for some patients with advanced lung cancer.
Apr 20, 2015
0
12
Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to research published in Cancer Cell ...
Apr 2, 2015
0
35
A study examined the feasibility of using circulating free DNA (cfDNA) from blood samples of patients with advanced non-small-cell lung cancer as a surrogate for tumor biopsies to determine tumor-causing epidermal growth ...
Feb 26, 2015
0
6
